The Children's Healthcare of Atlanta - Egleston Hospital is a nationally ranked, freestanding, 295-bed, pediatric acute care children's hospital located in Atlanta, Georgia.

There are 295 beds in Children's Healthcare of Atlanta - Egleston.

During the past decade, Children's Healthcare of Atlanta - Egleston conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 110 clinical trials were completed, i.e. on average, 90.2% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 53 clinical trials were completed. i.e. 129.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Healthcare of Atlanta - Egleston" #1 sponsor was "Children's Oncology Group" with 109 trials, followed by "National Cancer Institute (NCI)" with 77 trials sponsored, "Emory University" with 27 trials sponsored, "Children's Healthcare of Atlanta" with 12 trials sponsored and "Pfizer" with 12 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Healthcare of Atlanta - Egleston" #1 collaborator was "National Cancer Institute (NCI)" with 109 trials as a collaborator, "Children's Healthcare of Atlanta" with 12 trials as a collaborator, "Children's Oncology Group" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator and "Children's Hospital Medical Center, Cincinnati" with 3 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Children's Healthcare of Atlanta - Egleston" are "Recurrent Neuroblastoma" (30 trials), "Recurrent Malignant Solid Neoplasm" (24 trials), "Refractory Malignant Solid Neoplasm" (23 trials), "Recurrent Osteosarcoma" (22 trials) and "Refractory Neuroblastoma" (19 trials). Many other conditions were trialed in "Children's Healthcare of Atlanta - Egleston" in a lesser frequency.

Most popular intervention types in "Children's Healthcare of Atlanta - Egleston" are "Drug" (180 trials), "Other" (142 trials), "Biological" (67 trials), "Procedure" (66 trials) and "Radiation" (43 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (85 trials), "Cyclophosphamide" (45 trials), "Pharmacological Study" (43 trials), "Vincristine Sulfate" (39 trials) and "Questionnaire Administration" (33 trials). Other intervention names were less common.

The vast majority of trials in "Children's Healthcare of Atlanta - Egleston" are 265 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Children's Healthcare of Atlanta - Egleston". undefined are not yet recruiting, 50 are recruiting, 82 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 111 completed trials in Children's Healthcare of Atlanta - Egleston, 4 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Healthcare of Atlanta - Egleston, 43 "Phase 1" clinical trials were conducted, 90 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".